Two Romaco business units sold to Coesia

Published: 5-Apr-2006

US company Robbins &Myers has completed the sale of two of its Romaco business units - Hapa and Laetus - to Italian industrial group Coesia S.p.A. for approximately Euro 26m, effective 1 April, 2006.


US company Robbins &Myers has completed the sale of two of its Romaco business units - Hapa and Laetus - to Italian industrial group Coesia S.p.A. for approximately Euro 26m, effective 1 April, 2006.

"This strategic divestment of non-core businesses is an important step forward in reducing our complexity and becoming better focused," said Peter C. Wallace, president and ceo of Robbins & Myers.

"We believe in the excellent potential of Romaco's core competencies of packaging and processing and will pursue our drive for growth by further investing in this product portfolio and the underlying technologies.

"We will continue to work closely with Coesia to ensure a seamless transition of the Hapa and Laetus businesses for our customers."

  • Companies:
  • Laetus
See more

You may also like

Packaging

Reliable EU FMD compliance for late-starters

Read more
Laetus, an industry leader in inline quality inspection systems, is presenting new last-minute serialisation solutions for the pharmaceutical industry at ACHEMA

Trending Articles

  1. Optimising RNA production for faster and cheaper pharmaceutical manufacturing RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the avoidance of scaling issues
  2. ChargePoint invest in a single-use manufacturing facility to expand product line The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
  3. Memel Biotech and Therabest collaborate to develop exosome-based cell therapies The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
  4. Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
  5. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Packaging

Reliable EU FMD compliance for late-starters

Laetus, an industry leader in inline quality inspection systems, is presenting new last-minute serialisation solutions for the pharmaceutical industry at ACHEMA
Pharmaceutical

The next generation of serialisation

The serialisation platform Laetus UP sets new standards of usability without sacrificing reliability

Laetus and STADA agree on partnership for implementation of EU FMD

Track and Trace partnership will help with the EU Falsification Directive, 2019

Laetus at INTERPACK 2017

Laetus will be present at the event between 4 - 10 May, Hall 6, Booth A01 + Balcony
Digital

Next level of S-TTS software from Laetus

Laetus has released the S-TTS 2.6.0 version of its Secure-Track & Trace Solutions software (S-TTS)
Training & Education

The Track & Track Academy is more than just a training centre
Packaging

Laetus brings Secure Track and Trace to the next level

Laetus S-TTS 2.6.0 offers new capabilities to enhance the user experience
Subscribe now